Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer

The immune microenvironment is crucial for epithelial ovarian cancer (EOC) progression and consists of tumor-associated macrophages (TAM) and T lymphocytes, such as regulatory T cells (Treg) and T helper 17 (Th17) cells. In this study, the Treg/Th17 ratio was significantly higher in EOC and in metas...

Full description

Saved in:
Bibliographic Details
Published inCancer immunology research Vol. 6; no. 12; p. 1578
Main Authors Zhou, Jieru, Li, Xiaoduan, Wu, Xiaoli, Zhang, Ting, Zhu, Qinyi, Wang, Xinjing, Wang, Husheng, Wang, Kai, Lin, Yingying, Wang, Xipeng
Format Journal Article
LanguageEnglish
Published United States 01.12.2018
Online AccessGet more information
ISSN2326-6074
DOI10.1158/2326-6066.CIR-17-0479

Cover

Loading…
Abstract The immune microenvironment is crucial for epithelial ovarian cancer (EOC) progression and consists of tumor-associated macrophages (TAM) and T lymphocytes, such as regulatory T cells (Treg) and T helper 17 (Th17) cells. In this study, the Treg/Th17 ratio was significantly higher in EOC and in metastatic peritoneal tissues than in benign ovarian tumors and benign peritoneum. The Treg/Th17 ratio was associated with histologic grade and was an independent prognostic factor for overall survival of EOC patients. On the basis of microarray analysis of exosomes derived from TAMs, we identified miRNAs enriched in the exosomes, including miR-29a-3p and miR-21-5p. When the two miRNA mimics were transfected into CD4 T cells, they directly suppressed STAT3 and regulated Treg/Th17 cells, inducing an imbalance, and they had a synergistic effect on STAT3 inhibition. Taken together, these results indicate that exosomes mediate the interaction between TAMs and T cells, generating an immune-suppressive microenvironment that facilitates EOC progression and metastasis. These findings suggest that targeting these exosomes or their associated miRNAs might pave the way for the development of novel treatments for EOC.
AbstractList The immune microenvironment is crucial for epithelial ovarian cancer (EOC) progression and consists of tumor-associated macrophages (TAM) and T lymphocytes, such as regulatory T cells (Treg) and T helper 17 (Th17) cells. In this study, the Treg/Th17 ratio was significantly higher in EOC and in metastatic peritoneal tissues than in benign ovarian tumors and benign peritoneum. The Treg/Th17 ratio was associated with histologic grade and was an independent prognostic factor for overall survival of EOC patients. On the basis of microarray analysis of exosomes derived from TAMs, we identified miRNAs enriched in the exosomes, including miR-29a-3p and miR-21-5p. When the two miRNA mimics were transfected into CD4 T cells, they directly suppressed STAT3 and regulated Treg/Th17 cells, inducing an imbalance, and they had a synergistic effect on STAT3 inhibition. Taken together, these results indicate that exosomes mediate the interaction between TAMs and T cells, generating an immune-suppressive microenvironment that facilitates EOC progression and metastasis. These findings suggest that targeting these exosomes or their associated miRNAs might pave the way for the development of novel treatments for EOC.
Author Li, Xiaoduan
Zhou, Jieru
Zhang, Ting
Lin, Yingying
Zhu, Qinyi
Wang, Husheng
Wu, Xiaoli
Wang, Xipeng
Wang, Kai
Wang, Xinjing
Author_xml – sequence: 1
  givenname: Jieru
  surname: Zhou
  fullname: Zhou, Jieru
  organization: Department of Obstetrics and Gynaecology, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
– sequence: 2
  givenname: Xiaoduan
  surname: Li
  fullname: Li, Xiaoduan
  organization: Department of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China
– sequence: 3
  givenname: Xiaoli
  surname: Wu
  fullname: Wu, Xiaoli
  organization: Department of Obstetrics and Gynaecology, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
– sequence: 4
  givenname: Ting
  surname: Zhang
  fullname: Zhang, Ting
  organization: Center for Reproductive Medicine, Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China
– sequence: 5
  givenname: Qinyi
  surname: Zhu
  fullname: Zhu, Qinyi
  organization: Department of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China
– sequence: 6
  givenname: Xinjing
  surname: Wang
  fullname: Wang, Xinjing
  organization: Department of Obstetrics and Gynaecology, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
– sequence: 7
  givenname: Husheng
  surname: Wang
  fullname: Wang, Husheng
  organization: Department of Obstetrics and Gynaecology, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
– sequence: 8
  givenname: Kai
  surname: Wang
  fullname: Wang, Kai
  organization: Department of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China
– sequence: 9
  givenname: Yingying
  surname: Lin
  fullname: Lin, Yingying
  email: wangxipeng@xinhuamed.com.cn, yylin@sibs.ac.cn
  organization: Department of Neurosurgery, RenJi Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China. wangxipeng@xinhuamed.com.cn yylin@sibs.ac.cn
– sequence: 10
  givenname: Xipeng
  surname: Wang
  fullname: Wang, Xipeng
  email: wangxipeng@xinhuamed.com.cn, yylin@sibs.ac.cn
  organization: Department of Obstetrics and Gynaecology, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. wangxipeng@xinhuamed.com.cn yylin@sibs.ac.cn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30396909$$D View this record in MEDLINE/PubMed
BookMark eNo1kM1OwzAQhC0EoqX0EUB-gbS249jxsYoKRAIqVeFcrZNNE5Q_2SmCJ-C1CaLsZbTzjeYwN-Sy6zsk5I6zFedRvBahUIFiSq2SdB9wHTCpzQWZn30tZ2Tp_TubLo4lj-Q1mYUsNMowMyff28_e9y16uscGwWNBS9e3NDu1vQs23vd5DePkvkDu-qGC4xTNHHS-REfbev-6mf4KRpp2xSlHChPF4zqruKYJNg1NWwsNdBOqO7od6rHCpoaG7j7A1dDR5Je5W3JVQuNxedYFeXvYZslT8Lx7TJPNc5CHzIwBWKmZYSo2zKLAkPNcKKkUK0u0eVjEOpJCi9IKVkTammIawyoZay0ZL6QWC3L_1zucbIvFYXB1C-7r8L-I-AFO2mRW
CitedBy_id crossref_primary_10_1016_j_apsb_2023_03_025
crossref_primary_10_1016_j_intimp_2024_112406
crossref_primary_10_3389_fimmu_2023_1228331
crossref_primary_10_1007_s11064_021_03231_2
crossref_primary_10_1111_cas_14599
crossref_primary_10_1007_s11060_023_04257_y
crossref_primary_10_1002_cac2_12546
crossref_primary_10_1007_s10565_021_09650_9
crossref_primary_10_1186_s13045_022_01305_4
crossref_primary_10_1155_2019_4197829
crossref_primary_10_3390_biology9110380
crossref_primary_10_1007_s43032_021_00717_w
crossref_primary_10_3389_fimmu_2025_1525052
crossref_primary_10_1016_j_phymed_2021_153917
crossref_primary_10_1016_j_canlet_2022_215823
crossref_primary_10_3390_ijms23094493
crossref_primary_10_1007_s10565_023_09793_x
crossref_primary_10_3390_cancers12082025
crossref_primary_10_1186_s12951_023_02105_9
crossref_primary_10_3389_fimmu_2023_1270411
crossref_primary_10_4196_kjpp_2023_27_2_157
crossref_primary_10_1080_2162402X_2021_1887552
crossref_primary_10_3389_fimmu_2023_1264774
crossref_primary_10_1016_j_colsurfa_2021_128184
crossref_primary_10_1016_j_yexcr_2020_112393
crossref_primary_10_1016_j_ajps_2023_100870
crossref_primary_10_1016_j_ijbiomac_2023_126300
crossref_primary_10_3390_biomedicines9091257
crossref_primary_10_1016_j_bbcan_2021_188624
crossref_primary_10_1016_j_canlet_2022_215979
crossref_primary_10_1016_j_yexcr_2023_113621
crossref_primary_10_4251_wjgo_v16_i3_630
crossref_primary_10_1038_s41392_025_02124_y
crossref_primary_10_1186_s40364_022_00374_4
crossref_primary_10_1186_s12964_023_01408_6
crossref_primary_10_2147_OTT_S281909
crossref_primary_10_1016_j_ymthe_2021_08_003
crossref_primary_10_1021_acs_jafc_3c06104
crossref_primary_10_1016_j_canlet_2022_215975
crossref_primary_10_3389_fimmu_2021_590447
crossref_primary_10_1002_hed_26888
crossref_primary_10_3389_fendo_2022_886533
crossref_primary_10_1016_j_pharmthera_2020_107585
crossref_primary_10_1155_2021_3710372
crossref_primary_10_1007_s13205_022_03217_z
crossref_primary_10_3389_fimmu_2022_784374
crossref_primary_10_1016_j_jhepr_2024_101242
crossref_primary_10_3389_fimmu_2023_1320305
crossref_primary_10_1186_s13045_024_01528_7
crossref_primary_10_3389_fcell_2022_913110
crossref_primary_10_1016_j_intimp_2023_110415
crossref_primary_10_3390_jcm8070959
crossref_primary_10_1208_s12248_021_00554_4
crossref_primary_10_1038_s41523_022_00476_0
crossref_primary_10_1080_13880209_2023_2244004
crossref_primary_10_3389_fbioe_2022_876151
crossref_primary_10_3390_cells11203305
crossref_primary_10_1155_2019_4649705
crossref_primary_10_3390_cells10102533
crossref_primary_10_3389_fimmu_2023_1113312
crossref_primary_10_1016_j_ymthe_2020_06_003
crossref_primary_10_1186_s13046_021_01957_z
crossref_primary_10_1016_j_ejcb_2024_151447
crossref_primary_10_1002_smll_202105414
crossref_primary_10_3390_cancers14092220
crossref_primary_10_1111_1471_0528_17446
crossref_primary_10_3389_fphar_2022_895254
crossref_primary_10_1002_mco2_551
crossref_primary_10_3390_cells13161343
crossref_primary_10_3390_jcm9103226
crossref_primary_10_1007_s00281_023_00988_2
crossref_primary_10_3390_ijms22010014
crossref_primary_10_1167_iovs_64_4_28
crossref_primary_10_1186_s12943_024_02103_x
crossref_primary_10_1002_path_5403
crossref_primary_10_1186_s12943_023_01741_x
crossref_primary_10_31083_j_fbl2704139
crossref_primary_10_5306_wjco_v12_i10_845
crossref_primary_10_1002_cac2_12345
crossref_primary_10_1016_j_bbrep_2023_101542
crossref_primary_10_1016_j_celrep_2019_05_008
crossref_primary_10_3390_cancers13174380
crossref_primary_10_1128_MMBR_00064_19
crossref_primary_10_1186_s13046_022_02458_3
crossref_primary_10_1016_j_ymthe_2022_01_046
crossref_primary_10_1016_j_omtn_2021_05_011
crossref_primary_10_3390_ncrna7010004
crossref_primary_10_1016_j_phrs_2023_106756
crossref_primary_10_1097_QAI_0000000000002565
crossref_primary_10_1080_14737140_2020_1760095
crossref_primary_10_1038_s12276_021_00699_4
crossref_primary_10_3389_fdgth_2020_573010
crossref_primary_10_3389_fonc_2022_1004700
crossref_primary_10_3390_ijms23136994
crossref_primary_10_1016_j_mtbio_2022_100218
crossref_primary_10_3389_fimmu_2020_01525
crossref_primary_10_1038_s41392_021_00499_2
crossref_primary_10_1177_15330338221114497
crossref_primary_10_1186_s13071_019_3866_0
crossref_primary_10_3390_biomedicines11092534
crossref_primary_10_1038_s41419_024_07004_x
crossref_primary_10_1136_jitc_2021_002873
crossref_primary_10_1136_jitc_2022_005968
crossref_primary_10_1186_s12967_020_02652_x
crossref_primary_10_1016_j_actbio_2023_05_007
crossref_primary_10_1016_j_bcp_2024_116699
crossref_primary_10_1111_jcmm_16374
crossref_primary_10_3389_fphar_2024_1452276
crossref_primary_10_1111_sji_12807
crossref_primary_10_1016_j_ymthe_2021_12_002
crossref_primary_10_1002_EXP_20210144
crossref_primary_10_1016_j_ygyno_2024_09_019
crossref_primary_10_3389_fimmu_2022_913951
crossref_primary_10_1021_acsnano_4c09190
crossref_primary_10_3389_fonc_2024_1325575
crossref_primary_10_1016_j_apsb_2025_03_007
crossref_primary_10_1016_j_jconrel_2023_11_003
crossref_primary_10_1007_s00109_022_02276_2
crossref_primary_10_1038_s41423_024_01216_z
crossref_primary_10_1016_j_isci_2023_106333
crossref_primary_10_1186_s12943_020_01199_1
crossref_primary_10_3390_ijms23010008
crossref_primary_10_3390_ijms22073374
crossref_primary_10_1016_j_apsb_2020_04_004
crossref_primary_10_1016_j_trecan_2020_02_013
crossref_primary_10_1158_1535_7163_MCT_22_0351
crossref_primary_10_1007_s12094_023_03240_3
crossref_primary_10_1016_j_canlet_2021_12_007
crossref_primary_10_2217_epi_2019_0165
crossref_primary_10_3389_fimmu_2021_593473
crossref_primary_10_1136_jitc_2021_004113
crossref_primary_10_1002_cam4_3505
crossref_primary_10_1016_j_prp_2024_155261
crossref_primary_10_32604_or_2023_030401
crossref_primary_10_1007_s00018_022_04164_x
crossref_primary_10_1080_08923973_2024_2412110
crossref_primary_10_3390_ijms24119279
crossref_primary_10_3390_ijms21072286
crossref_primary_10_3390_ijms21197093
crossref_primary_10_1016_j_lfs_2020_118687
crossref_primary_10_1097_CM9_0000000000003078
crossref_primary_10_1007_s43032_021_00789_8
crossref_primary_10_3390_cancers15061650
crossref_primary_10_1007_s00262_024_03674_w
crossref_primary_10_3390_cells9092061
crossref_primary_10_1016_j_semcdb_2023_01_008
crossref_primary_10_1021_acsbiomaterials_2c00893
crossref_primary_10_1111_cei_13639
crossref_primary_10_1186_s13045_020_00987_y
crossref_primary_10_1186_s13045_021_01198_9
crossref_primary_10_3892_ijo_2022_5347
crossref_primary_10_3389_fonc_2023_1166860
crossref_primary_10_1126_sciadv_abb0737
crossref_primary_10_3389_fgene_2022_848985
crossref_primary_10_1002_ctm2_288
crossref_primary_10_1002_pro6_66
crossref_primary_10_1007_s10565_022_09744_y
crossref_primary_10_3390_ijms20102401
crossref_primary_10_3390_cancers14143404
crossref_primary_10_3892_ijo_2022_5450
crossref_primary_10_1002_pmic_202200204
crossref_primary_10_1186_s12935_022_02594_y
crossref_primary_10_1002_jcp_28905
crossref_primary_10_1016_j_bbadis_2023_166917
crossref_primary_10_1016_j_nantod_2023_102129
crossref_primary_10_3390_biom14091099
crossref_primary_10_1016_j_jare_2024_01_013
crossref_primary_10_1186_s12885_021_08729_0
crossref_primary_10_1080_21691401_2019_1596926
crossref_primary_10_1016_j_imlet_2020_08_003
crossref_primary_10_3389_fimmu_2022_923194
crossref_primary_10_3389_fimmu_2023_1161375
crossref_primary_10_3389_fonc_2020_00472
crossref_primary_10_1111_febs_15558
crossref_primary_10_1007_s13105_024_01050_x
crossref_primary_10_3389_fmicb_2023_1115556
crossref_primary_10_3389_fimmu_2021_641937
crossref_primary_10_3390_ijms21197117
crossref_primary_10_1016_j_bioactmat_2023_09_018
crossref_primary_10_1002_wnan_2012
crossref_primary_10_1016_j_semcancer_2021_01_007
crossref_primary_10_1146_annurev_cancerbio_042920_104912
crossref_primary_10_1038_s41392_021_00506_6
crossref_primary_10_3390_ijms21228762
crossref_primary_10_1007_s00262_022_03305_2
crossref_primary_10_1155_2022_9719671
crossref_primary_10_3390_ijms20236016
crossref_primary_10_1016_j_jpha_2023_11_008
crossref_primary_10_1136_jitc_2021_003217
crossref_primary_10_1002_cam4_3252
crossref_primary_10_1089_ars_2022_0035
crossref_primary_10_1158_1940_6207_CAPR_20_0053
crossref_primary_10_1016_j_semcdb_2021_04_001
crossref_primary_10_1002_ctm2_1425
crossref_primary_10_1016_j_semcancer_2021_08_001
crossref_primary_10_1186_s12943_025_02282_1
crossref_primary_10_1631_jzus_B1900452
crossref_primary_10_3390_cells10113155
crossref_primary_10_1007_s00262_020_02616_6
crossref_primary_10_3390_cells10010056
crossref_primary_10_1002_adbi_201900008
crossref_primary_10_1007_s00432_023_04833_9
crossref_primary_10_3389_fimmu_2022_1050917
crossref_primary_10_3390_cancers11091280
crossref_primary_10_1016_j_canlet_2024_216610
crossref_primary_10_1097_HC9_0000000000000616
crossref_primary_10_1186_s40364_023_00538_w
crossref_primary_10_3390_cancers12010024
crossref_primary_10_1016_j_semcdb_2021_04_013
crossref_primary_10_3389_fimmu_2022_1018256
crossref_primary_10_1002_ijc_33408
crossref_primary_10_3389_fimmu_2021_669992
crossref_primary_10_1038_s41419_020_03127_z
crossref_primary_10_1038_s41419_022_04534_0
crossref_primary_10_1002_jcp_28785
crossref_primary_10_1016_j_hbpd_2024_04_004
crossref_primary_10_1186_s12935_024_03525_9
crossref_primary_10_3390_ijms21051673
crossref_primary_10_1002_advs_201900582
crossref_primary_10_3389_fonc_2021_631703
crossref_primary_10_1016_j_jep_2022_116086
crossref_primary_10_1016_j_heliyon_2024_e30603
crossref_primary_10_1002_adbi_202000061
crossref_primary_10_1016_j_pharmthera_2021_107969
crossref_primary_10_1111_prd_12520
crossref_primary_10_3389_fimmu_2023_1287465
crossref_primary_10_3390_cancers12113455
crossref_primary_10_1002_advs_202309298
crossref_primary_10_3389_fphar_2023_1082066
crossref_primary_10_1038_s41419_021_03490_5
crossref_primary_10_1016_j_intimp_2024_113248
crossref_primary_10_1080_14737159_2020_1688144
crossref_primary_10_1016_j_intimp_2024_112150
crossref_primary_10_3390_biomedicines9101494
crossref_primary_10_14336_AD_2021_1023
crossref_primary_10_1007_s40618_020_01401_7
crossref_primary_10_1002_iid3_743
crossref_primary_10_1186_s40364_023_00537_x
crossref_primary_10_1016_j_bbcan_2022_188784
crossref_primary_10_1021_acsnano_1c00672
crossref_primary_10_1038_s41392_021_00484_9
crossref_primary_10_3389_frph_2023_1130849
crossref_primary_10_3390_jnt3010005
crossref_primary_10_1002_adhm_202100650
crossref_primary_10_1016_j_addr_2021_113838
crossref_primary_10_1186_s13048_024_01417_0
crossref_primary_10_1186_s12943_020_01278_3
crossref_primary_10_1166_jbn_2021_3066
crossref_primary_10_3389_fimmu_2022_1071223
crossref_primary_10_3390_cancers12030561
crossref_primary_10_1210_endocr_bqae127
crossref_primary_10_1038_s41368_020_00100_6
crossref_primary_10_1016_j_semcancer_2024_08_006
crossref_primary_10_1016_j_ygyno_2021_02_004
crossref_primary_10_1186_s12943_024_01967_3
crossref_primary_10_1080_13543784_2024_2360209
crossref_primary_10_1016_j_cytogfr_2022_07_005
crossref_primary_10_1051_e3sconf_202129203089
crossref_primary_10_1038_s41419_024_06494_z
crossref_primary_10_1038_s41419_022_04510_8
crossref_primary_10_1016_j_intimp_2022_109605
crossref_primary_10_3390_cancers12071761
ContentType Journal Article
Copyright 2018 American Association for Cancer Research.
Copyright_xml – notice: 2018 American Association for Cancer Research.
DBID NPM
DOI 10.1158/2326-6066.CIR-17-0479
DatabaseName PubMed
DatabaseTitle PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 2326-6074
ExternalDocumentID 30396909
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 53G
ADCOW
AENEX
AFHIN
AFUMD
ALMA_UNASSIGNED_HOLDINGS
EBS
EJD
H13
NPM
OK1
RCR
RHI
ID FETCH-LOGICAL-c309t-ab470906890be2e311c264660ffebc3d8754272fb20d57b9d047b64877401d472
IngestDate Thu Apr 03 07:03:02 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License 2018 American Association for Cancer Research.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c309t-ab470906890be2e311c264660ffebc3d8754272fb20d57b9d047b64877401d472
PMID 30396909
ParticipantIDs pubmed_primary_30396909
PublicationCentury 2000
PublicationDate 2018-12-00
PublicationDateYYYYMMDD 2018-12-01
PublicationDate_xml – month: 12
  year: 2018
  text: 2018-12-00
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cancer immunology research
PublicationTitleAlternate Cancer Immunol Res
PublicationYear 2018
SSID ssj0000884154
Score 2.594436
Snippet The immune microenvironment is crucial for epithelial ovarian cancer (EOC) progression and consists of tumor-associated macrophages (TAM) and T lymphocytes,...
SourceID pubmed
SourceType Index Database
StartPage 1578
Title Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/30396909
Volume 6
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1ba9swFIBF2kHpy-jud_Swt6DWF1m2H0vIaAftIKQs7KVYlrwYmjhkcSn7A_0v_ZU7R5fEpB10ezGJZITR-dA5OpwLIZ91IYRKVcxAO0nGFeesAE3IeJILXkgVl8YPeXYuTi7410ky6fXuOlFL7Uoelr8fzCv5H6nCGMgVs2T_QbLrRWEAfoN84QkShuejZDy8aX41WG1pBMoD1JGy2SLjdtYsmd94jYEU2KhrWmA9B6OcKr3sz-rR-TH8nxarPjbwwMwBmNU_sZ7INEz7A3Trnc4kBj-WprbIcIEZHFfoZP92DZdsOBsGOLfsmrh2pF9j4okt8OQKCq0dzz-mTWvoAZXcriOCTFjBpC4a1W6I_d760av6no977NWu81qEWScCRJvTDSw5wURgW_T4o1h0iYs652qY2EY_9w_8BJMY3GJCHA5ORwz0LhbO774PclvMDAWgsnORB4-Y3arD7ad2yA7cSLDFqvMLGZ2fZWAJcZciBh919OAn7ZM9v8zWNcaYM-MD8tTdQ-ixheoZ6en5c7J35iItXpBbzxb1bFFki26zRTtsUc8WtWxRZItatmhBka0jJIsiWXRNFq3ndEMWdWRRy9FLcvFlOB6cMNe0g5VxkK9YIXka5IHI8kDqSMdhWILNLURQVVqWscqw5XIaVTIKVJLKXMG-SAHXZmwNqXgavSK782au3xCqq0xHVax0kkQc3sxSGedJWYEJH1Vc6bfktd3Cy4WtzHLpN_fdX2fek_0Njh_IkwqOAv0R7MqV_GRE-gfXCXYF
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exosomes+Released+from+Tumor-Associated+Macrophages+Transfer+miRNAs+That+Induce+a+Treg%2FTh17+Cell+Imbalance+in+Epithelial+Ovarian+Cancer&rft.jtitle=Cancer+immunology+research&rft.au=Zhou%2C+Jieru&rft.au=Li%2C+Xiaoduan&rft.au=Wu%2C+Xiaoli&rft.au=Zhang%2C+Ting&rft.date=2018-12-01&rft.eissn=2326-6074&rft.volume=6&rft.issue=12&rft.spage=1578&rft_id=info:doi/10.1158%2F2326-6066.CIR-17-0479&rft_id=info%3Apmid%2F30396909&rft_id=info%3Apmid%2F30396909&rft.externalDocID=30396909